|
⚲
|
| Keyboard |
| POHL David
✚
|
|
|---|---|
| CIK # | 0001233396 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 4 | [0001233396] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Peregrine Pharmaceuticals Inc | |
| POHL David |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Peregrine Pharmaceuticals Inc PPHM
Stock Option (right to buy) · derivative
|
2017-08-25 | Other | 11,908 | $0.00 | |
|
Peregrine Pharmaceuticals Inc PPHM
Stock Option (right to buy) · derivative
|
2016-06-02 | Grant | 200,000 | $0.00 | |
|
Peregrine Pharmaceuticals Inc PPHM
Stock Option (right to buy) · derivative
|
2015-05-11 | Grant | 187,500 | $0.00 | |
|
Peregrine Pharmaceuticals Inc PPHM
Stock Option (right to buy) · derivative
|
2014-05-06 | Grant | 250,000 | $0.00 | |
|
Peregrine Pharmaceuticals Inc PPHM
Stock Option (right to buy) · derivative
|
2013-05-06 | Grant | 250,000 | $0.00 | |
|
Peregrine Pharmaceuticals Inc PPHM
Stock Option (right to buy) · derivative
|
2012-12-27 | Grant | 250,000 | $0.00 | |
|
Peregrine Pharmaceuticals Inc PPHM
Non-Qualified Stock Options (right to buy) · derivative
|
2012-05-04 | Grant | 250,000 | $0.00 | |
|
Peregrine Pharmaceuticals Inc PPHM
Non-Qualified Stock Options (right to buy) · derivative
|
2012-02-17 | Grant | 90,000 | $0.00 |